Pyxis Oncology, Inc. (PYXS) Operating margin 2024–2025
Pyxis Oncology, Inc. (PYXS) operating margin by fiscal year — reported operating income divided by reported revenue.
-609.2%FY2025 · since FY2024: -554.1% → -609.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -609.2% | -55.1 pp |
| FY2024 | -554.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →